Research Comparison
Retatrutide vs Semaglutide
A side-by-side research comparison of Retatrutide and Semaglutide drawn from DRPSHP' peptide database records.
Retatrutide
Retatrutide (development code LY3437943) is a synthetic peptide designed to stimulate three hormone receptors at once: those for GIP, GLP-1 and glucagon. GIP and GLP-1 are incretins, hormones the gut releases in response to food, while glucagon comes from the alpha cells of the pancreas, and all three receptors belong to one family. Earlier synthetic agonists of this family acted on one or two of the receptors; retatrutide's distinguishing feature is engaging all three. Its pharmacology has been described in cell assays and animal studies, and it has been examined in human clinical trials in metabolic disease.
Semaglutide
Semaglutide is best understood as human GLP-1 re-engineered so that it lasts. The native hormone is a 31-residue peptide destroyed in the bloodstream within a couple of minutes; semaglutide keeps the 31-residue frame but swaps in three changes, referenced to native numbering. Position 8 carries aminoisobutyric acid (Aib) so that dipeptidyl peptidase-4 cannot clip it, position 34 holds arginine instead of lysine, and the lysine at position 26 bears an 18-carbon diacid chain on a short spacer that lets the molecule ride on albumin. Receptor pharmacology, rodent models and a very extensive human trial record in metabolic disease all exist. A live question is how an albumin-bound molecule of this size reaches the brain regions where the receptor sits.
Reading a comparison
A comparison places two records side by side; it does not merge them. Each description above is drawn from that compound's own record, and the two were not necessarily characterised by the same methods, at the same time, or to the same level of detail. Before comparing any attribute, it is worth establishing that both records describe the substance you think they describe — names are not identifiers, and two entries sharing a name can differ in salt form, stereochemistry or the convention used to state a mass. Where a figure carries no method beside it, the comparison is between two reported numbers rather than between two measurements.